InspireMD, Inc. (FRA:II2)
Germany
· Delayed Price · Currency is EUR 1.570
-0.020 (-1.26%)
At close: Dec 4, 2025
InspireMD Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 7.78 | 7.01 | 6.21 | 5.17 | 4.5 | 2.49 | Upgrade
|
| Revenue Growth (YoY) | 14.04% | 12.96% | 20.00% | 15.04% | 80.88% | -33.22% | Upgrade
|
| Cost of Revenue | 5.84 | 5.5 | 4.4 | 4.05 | 3.74 | 2.4 | Upgrade
|
| Gross Profit | 1.94 | 1.51 | 1.81 | 1.12 | 0.75 | 0.08 | Upgrade
|
| Selling, General & Admin | 33.61 | 21.38 | 14.97 | 12.02 | 10.31 | 7.8 | Upgrade
|
| Research & Development | 15.22 | 13.63 | 7.98 | 7.81 | 5.16 | 2.23 | Upgrade
|
| Operating Expenses | 48.84 | 35.01 | 22.95 | 19.83 | 15.47 | 10.03 | Upgrade
|
| Operating Income | -46.9 | -33.5 | -21.14 | -18.71 | -14.72 | -9.95 | Upgrade
|
| Interest Expense | - | - | - | - | -0.16 | -0.16 | Upgrade
|
| Interest & Investment Income | 0.76 | 1.56 | 1.29 | 0.25 | - | - | Upgrade
|
| EBT Excluding Unusual Items | -46.14 | -31.95 | -19.85 | -18.46 | -14.87 | -10.11 | Upgrade
|
| Legal Settlements | - | - | - | - | - | -0.43 | Upgrade
|
| Pretax Income | -46.14 | -31.95 | -19.85 | -18.46 | -14.87 | -10.54 | Upgrade
|
| Income Tax Expense | 0.06 | 0.06 | 0.07 | 0.03 | 0.05 | 0 | Upgrade
|
| Net Income | -46.2 | -32.01 | -19.92 | -18.49 | -14.92 | -10.54 | Upgrade
|
| Net Income to Common | -46.2 | -32.01 | -19.92 | -18.49 | -14.92 | -10.54 | Upgrade
|
| Shares Outstanding (Basic) | 56 | 42 | 24 | 8 | 7 | 2 | Upgrade
|
| Shares Outstanding (Diluted) | 56 | 42 | 24 | 8 | 7 | 2 | Upgrade
|
| Shares Change (YoY) | 47.64% | 72.77% | 208.29% | 7.16% | 385.71% | 985.50% | Upgrade
|
| EPS (Basic) | -0.82 | -0.76 | -0.82 | -2.35 | -2.03 | -6.97 | Upgrade
|
| EPS (Diluted) | -0.82 | -0.76 | -0.82 | -2.35 | -2.03 | -6.97 | Upgrade
|
| Free Cash Flow | -34.08 | -23.27 | -16.76 | -16.02 | -13.55 | -9.17 | Upgrade
|
| Free Cash Flow Per Share | -0.61 | -0.56 | -0.69 | -2.03 | -1.84 | -6.06 | Upgrade
|
| Gross Margin | 24.91% | 21.49% | 29.12% | 21.60% | 16.77% | 3.34% | Upgrade
|
| Operating Margin | -602.87% | -478.00% | -340.74% | -361.88% | -327.39% | -400.40% | Upgrade
|
| Profit Margin | -593.89% | -456.63% | -320.97% | -357.59% | -331.88% | -424.31% | Upgrade
|
| Free Cash Flow Margin | -438.14% | -332.00% | -270.06% | -309.71% | -301.54% | -368.97% | Upgrade
|
| EBITDA | -46.49 | -33.22 | -20.91 | -18.53 | -14.56 | -9.8 | Upgrade
|
| D&A For EBITDA | 0.41 | 0.28 | 0.23 | 0.19 | 0.16 | 0.15 | Upgrade
|
| EBIT | -46.9 | -33.5 | -21.14 | -18.71 | -14.72 | -9.95 | Upgrade
|
| Advertising Expenses | - | 0.69 | 0.43 | 0.36 | 0.29 | 0.16 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.